Evaluation of the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia in the secondary health care in the Brazilian Unified Health System (SUS). Braz. J. Pharm. Sci. 2022;58. doi:10.1590/s2175-97902022e20400